Optimum Treatment of Stable Angina: Update 2013
Udho Thadani, MD, MRCP, FRCPC, FACC, FHAH, Professor Emeritus, Department of Medicine/Cardiovascular Diseases
Upon completion of this activity, participants will be able to: Review pathophysiology of stable angina. To review available treatment options. To review impact on serious adverse outcomes and on symptoms. To explain optimal therapy. To review what is new and on the horizon.
Disclosure Report: Course Director: Dr. C. A. Sivaram is a consultant and receives honoraria for Medtronic, Inc. Planning Committee Member: Dr. Dwight Reynolds has received grants/research support from Medtronic, Inc. and is a consultant and received honorarium from Medtronic, Inc. and Sorin. Dr. Faisal Latif has no financial relationships or affiliations to disclose. Course Contact: Kelsey Peters has no financial relationships or affiliations to disclose. Speaker Disclosure: Udho Thadani, MD is a local PI for research studies for which OUHSC and VA Medical Center receive grant support to conduct the studies with no salary support for Dr. Thadani, he is also a consultant and receives honoraria for Servier, Gilead Science and Arbor Pharmaceuticals.
Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Eery reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.
For more information contact:
Department of Medicine/Cardiovascular Diseases